European Journal of Medicinal Chemistry

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

European Journal of Medicinal Chemistry is a journal published by Elsevier BV in France. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,710 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1768-3254 · 0223-5234
Country
France
Access
Not open access / not declared
Declared publication charge
4,710 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2000-01-01
  • PUBMED · 2006-10-16
Indexing
MEDLINE · PUBMED
APC
4,710 USD
Declared review time (DOAJ)
—
Actual review time (measured)
66 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

19107

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

237

i10-index

13616

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
71%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
0420510
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Synthesis and biological activity
  • Synthesis and biological activity
  • Synthesis and biological activity
  • Synthesis and Characterization of Heterocyclic Compounds
  • Computational Drug Discovery Methods
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
  • Cancer therapeutics and mechanisms
Show all subjects (75)
  • Cancer therapeutics and mechanisms
  • Synthesis and Biological Evaluation
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Bioactive Compounds and Antitumor Agents
  • Bioactive Compounds and Antitumor Agents
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and Characterization of Heterocyclic Compounds
  • Cholinesterase and Neurodegenerative Diseases
  • Metal complexes synthesis and properties
  • Quinazolinone synthesis and applications
  • Quinazolinone synthesis and applications
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Structural and Chemical Analysis of Organic and Inorganic Compounds
  • Metal complexes synthesis and properties
  • Metal complexes synthesis and properties
  • Chemical Synthesis and Analysis
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Chemical Synthesis and Analysis
  • Chemical Synthesis and Analysis
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Bioactive Compounds and Antitumor Agents
  • Alzheimer's disease research and treatments
  • Protein Degradation and Inhibitors
  • Natural product bioactivities and synthesis
  • Enzyme function and inhibition
  • Synthesis of Organic Compounds
  • Receptor Mechanisms and Signaling
  • Biochemical and Molecular Research
  • Biochemical and Molecular Research
  • Synthesis and bioactivity of alkaloids
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Bioactive natural compounds
  • Cancer therapeutics and mechanisms
  • Pharmacological Receptor Mechanisms and Effects
  • Pharmacological Receptor Mechanisms and Effects
  • Antimicrobial agents and applications
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Research on Leishmaniasis Studies
  • Research on Leishmaniasis Studies
  • Histone Deacetylase Inhibitors Research
  • Multicomponent Synthesis of Heterocycles
  • Multicomponent Synthesis of Heterocycles
  • Synthesis of Organic Compounds
  • Synthesis of Organic Compounds
  • HIV/AIDS drug development and treatment
  • Quinazolinone synthesis and applications
  • Inflammatory mediators and NSAID effects
  • Chemical synthesis and pharmacological studies
  • Carbohydrate Chemistry and Synthesis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: